James Harvey, M.D. v. HHS - Influenza, leukocytoclastic vasculitis and post-vaccine polyneuritis (2025)

Dr. James Harvey, a 76-year-old retired surgeon, filed a petition for compensation under the National Vaccine Injury Compensation Program on May 13, 2020.

He alleged that an influenza vaccine administered on October 6, 2017, caused him to develop leukocytoclastic vasculitis (IgAV) and subsequently polyneuritis. Dr.

Harvey had pre-existing conditions including asthma and diabetes. He reported experiencing a rash on his legs within hours of the vaccination.

Six days later, on October 12, 2017, he was diagnosed with IgAV by a dermatologist, Dr. Kari Boucher, and was prescribed topical cream and prednisone.

The rash persisted, and a subsequent biopsy confirmed IgAV. Dr.

Harvey's IgAV symptoms subsided within a few weeks. Later, he experienced neuropathy.

Dr. Harvey argued that the flu vaccine caused his IgAV, which in turn caused his neuropathy.

The Secretary of Health and Human Services disputed Dr. Harvey's claim.

Both parties submitted expert reports and legal arguments. Special Master Christian J.

Moran issued a published decision on March 18, 2025, denying Dr. Harvey's petition.

The Special Master found that Dr. Harvey failed to prove by a preponderance of the evidence that the flu vaccine was the cause-in-fact of his IgAV, specifically failing to meet the requirements of the Althen test.

The Special Master found Dr. Harvey's medical theory connecting the vaccine to IgAV to be unpersuasive and lacking in detail, particularly regarding the role of cytokines, complement, and immune complexes in relation to defective IgA.

Furthermore, the Special Master determined that the temporal relationship between the vaccination and the onset of IgAV was not within the medically acceptable timeframe, citing expert opinions that suggested a minimum of three days for IgAV onset following an exposure, whereas Dr. Harvey's symptoms appeared within 24 hours.

The Special Master also found that the logical sequence of cause and effect was not established, partly due to the weaknesses in the other two prongs of the Althen test and the reliance on Dr. Harvey's own reports of vaccine association rather than independent physician opinions.

The Special Master did not reach the issue of severity, as entitlement was not established. Dr.

Harvey petitioned for review of the Special Master's decision. On October 6, 2025, Chief Judge Matthew H.

Solomson of the U.S. Court of Federal Claims issued an opinion affirming the Special Master's decision.

The Court found that the Special Master's analysis of the second Althen prong (logical sequence of cause and effect) was not arbitrary or capricious, noting that the Special Master carefully considered the views of treating physicians and provided a reasoned basis for weighing conflicting opinions, particularly favoring the opinion of immunologist Dr. David Lang over that of Dr.

Rebecca Kuenzler regarding the timing of vaccine reactions. While the Court noted that the Special Master's reasoning for the first and third Althen prongs was less developed and potentially conclusory, it found that the strong reasoning for the second prong was sufficient to affirm the denial of compensation.

The Court agreed that Dr. Harvey did not meet his burden to prove by a preponderance of the evidence that the flu vaccine was the cause-in-fact of his IgAV.

Therefore, Dr. Harvey's petition for compensation was denied.